期刊文献+

毒黄素对非小细胞肺癌A549细胞株作用的实验研究 被引量:6

Experimental study of toxoflavin on human non-small cell lung cancer cells A549
下载PDF
导出
摘要 目的研究毒黄素不同浓度和不同作用时间对非小细胞肺癌A549细胞增殖、凋亡和迁移的影响。方法分别取0.5、0.375、0.25和0.125μmol/L毒黄素作用于A549细胞(实验组),以不加毒黄素为对照组,分别培养24 h和48 h。采用CCK-8试剂盒、Annexin V-FITC/PI凋亡试剂盒检测A549细胞增殖抑制率和凋亡率。划痕实验对比0.125μmol/L毒黄素组和对照组(0μmol/L毒黄素)在12、24和48 h细胞迁移率。结果 0.5、0.375、0.25和0.125μmol/L毒黄素组24 h细胞增殖抑制率分别为(93.51±3.69)%、(40.38±3.08)%、(23.54±2.58)%和(13.07±2.37)%,48 h为(90.53±3.58)%、(53.72±3.02)%、(34.44±3.10)%和(24.78±2.43)%。0.5、0.375、0.25和0.125μmol/L毒黄素组24 h细胞凋亡率分别为(78.68±2.22)%、(43.66±2.53)%、(20.81±2.59)%和(6.25±0.96)%,高于对照组的(1.57±0.52)%;0.5、0.375、0.25和0.125μmol/L毒黄素组48 h细胞凋亡率分别为(88.66±3.16)%、(59.86±2.81)%、(27.89±3.48)%和(9.91±1.33)%,高于对照组的(1.59±0.55)%。0.125μmol/L毒黄素组12、24和48 h细胞迁移率分别为7%、11%和16%,低于对照组相应的14%、26%和39%。结论毒黄素对A549细胞有明显增殖抑制和促凋亡作用,并呈时间和剂量依赖性,且可抑制A549细胞迁移活性。 Objective To investigate the inhibitory effects of toxoflavin on proliferation, apoptosis and migration of non-small cell lung cancer A549 cells. Methods The cultured A549 cells were treated with toxoflavin(0. 5, 0. 375, 0. 25, 0. 125 p, mol/L) for 24 h and 48 h, the control group was treated with ceil culture media only. CCK-8 assay was used to test the growth inhibitory rate and Annexin V/propidium iodide(PI) staining assay was applied to detect the apoptosis rate. The cell migration rate of 12 h, 24 h, 48 h were measured by the wound healing assay. Results The cell growth inhibition rates of A549 cells in experimental groups were ( 93.51 ±3.69)%, (40. 38±3.08)%, (23.54±2. 58)%, ( 13.07±2. 37)% in 24 h and(90. 53±3.58)%, (53.72±3.02)%, (34.44± 3.10) %, (24. 78±2.43)% in 48 h. The cell apoptosis rates of A549 cells in expremental groups were (78.68±2. 22)%, (43.66± 2.53)%,(20. 81±2.59)%,(6.25±0.96)% in 24 h and(88. 66±3.16)%, (59. 86±2. 81)%,(27.89±3.48)%,(9.91±1.33)% in 48 h, and those of control group were( 1.57±0. 52)% in 24 h and ( 1.59±0. 55 )% in 48 h respectively. The A549 cell migration rate of 12 h, 24 h ,48 h in experimental group( 0. 125 p, mol/L) was 7%, 11% and 16% ), but it was 14%, 26% and 39% in control group. Conclusion Toxoflavin could significantly inhibit proliferation and promote apoptosis of A549 cells in a dose and time depend- ent manner, and it could also weaken the migration capacity of A549 cells.
出处 《临床肿瘤学杂志》 CAS 2016年第2期117-120,共4页 Chinese Clinical Oncology
基金 常州市科技局国际科技合作项目(CZ20140016)
关键词 毒黄素 非小细胞肺癌 增殖 凋亡 迁移 Toxoflavin Non-small cell lung cancer(NSCLC) Proliferation Apoptosis Migration
  • 相关文献

参考文献9

  • 1Ozgul MA, Kirkil G, Seyhan EC, et al. The maximum standard- ized FDG uptake on PET-CT in patients with non-small cell lung cancer [ J ]. Multidiscip Respir Med, 2013,8 ( 1 ) : 69.
  • 2Chang A. Chemotherapy, chemoresistance and the changing treat- ment landscape for NSCLC [ J]. Lung Cancer, 2011,71 ( 1 ) : 3 -10.
  • 3Forde PM, Ettinger DS. Targeted therapy for non-small-cell lung cancer: past, present and future [ J ]. Expert Rev Anticancer Ther, 2013,13(6) :745-758.
  • 4Hallett RM, Kondratyev MK, Giaeomelli AO, et al. Small mole- cule antagonists of the Wnt/beta-eatenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer [ J/OL ]. PLoS One, 2012 [ 2015-10-13 ]. http:// pubmedeentraleanada, eafpmcc/articles/PMC3314694/.
  • 5Mathur R, Sehgal L, Braun FK, et al. Targeting Wnt pathway in mantle cell lymphoma-initiating cells [ J ]. J Hematol Oncol, 2015,8( 1 ) :1-12.
  • 6Choi G, Lee J, Ji JY, et al. Discovery of a potent small molecule SIRT1/2 inhibitor with antieaneer effects[ J]. Int J Oncol, 2013, 43(4) : 1205-1211.
  • 7Li C, Wang L, Zheng L, et al. SIRT1 expression is associated with poor prognosis of lung adenocareinoma[ J]. Onco Targets T- her, 2015,8:977-984.
  • 8Antony L, van der Schoor F, Dalrymple SL, et al. Androgen re- ceptor(AR) suppresses normal human prostate epithelial cell proliferation via AR/beta-eatenin/TCF-4 complex inhibition of c- MYC transcription [ J ]. Prostate, 2014,74 ( 11 ) : 1118-1131.
  • 9Wei W, Chua MS, Grepper S, et al. Small molecule antagonists of Tef4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo[J]. Int J Cancer, 2010,126(10) :2426-2436.

同被引文献46

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部